288 related articles for article (PubMed ID: 32124504)
1. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
[TBL] [Abstract][Full Text] [Related]
2. JOURNAL CLUB: The Warthin Tumor Score: A Simple and Reliable Method to Distinguish Warthin Tumors From Pleomorphic Adenomas and Carcinomas.
Wang CW; Chu YH; Chiu DY; Shin N; Hsu HH; Lee JC; Juan CJ
AJR Am J Roentgenol; 2018 Jun; 210(6):1330-1337. PubMed ID: 29667889
[TBL] [Abstract][Full Text] [Related]
3. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings.
Yamamoto T; Kimura H; Hayashi K; Imamura Y; Mori M
Neuroradiology; 2018 Aug; 60(8):803-812. PubMed ID: 29968073
[TBL] [Abstract][Full Text] [Related]
4. Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors.
Razek AAKA
Magn Reson Imaging; 2019 Nov; 63():55-59. PubMed ID: 31422165
[TBL] [Abstract][Full Text] [Related]
5. Intravoxel Incoherent Motion Magnetic Resonance Imaging for Assessing Parotid Gland Tumors: Correlation and Comparison with Arterial Spin Labeling Imaging.
Ma G; Xu XQ; Zhu LN; Jiang JS; Su GY; Hu H; Bu SS; Wu FY
Korean J Radiol; 2021 Feb; 22(2):243-252. PubMed ID: 32932565
[TBL] [Abstract][Full Text] [Related]
6. Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization?
Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Nakashima T; Oda Y; Honda H
Radiology; 2008 Dec; 249(3):909-16. PubMed ID: 18941162
[TBL] [Abstract][Full Text] [Related]
7. Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging.
Matsusue E; Fujihara Y; Matsuda E; Tokuyasu Y; Nakamoto S; Nakamura K; Ogawa T
Clin Imaging; 2017; 46():37-43. PubMed ID: 28704680
[TBL] [Abstract][Full Text] [Related]
8. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors.
Mikaszewski B; Markiet K; Smugała A; Stodulski D; Szurowska E; Stankiewicz C
Oral Oncol; 2020 Dec; 111():104932. PubMed ID: 32739792
[TBL] [Abstract][Full Text] [Related]
9. Application of DTI and ARFI imaging in differential diagnosis of parotid tumours.
Yu J; Du Y; Lu Y; Zhang W; Zhang D; Wang G; Li C
Dentomaxillofac Radiol; 2016; 45(6):20160100. PubMed ID: 27351345
[TBL] [Abstract][Full Text] [Related]
10. A triple-classification radiomics model for the differentiation of pleomorphic adenoma, Warthin tumour, and malignant salivary gland tumours on the basis of diffusion-weighted imaging.
Shao S; Zheng N; Mao N; Xue X; Cui J; Gao P; Wang B
Clin Radiol; 2021 Jun; 76(6):472.e11-472.e18. PubMed ID: 33752882
[TBL] [Abstract][Full Text] [Related]
11. T2 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging for the differentiation of parotid gland tumors.
Baohong W; Jing Z; Zanxia Z; Kun F; Liang L; Eryuan G; Yong Z; Fei H; Jingliang C; Jinxia Z
Eur J Radiol; 2022 Jun; 151():110265. PubMed ID: 35472650
[TBL] [Abstract][Full Text] [Related]
12. Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla.
Fruehwald-Pallamar J; Czerny C; Holzer-Fruehwald L; Nemec SF; Mueller-Mang C; Weber M; Mayerhoefer ME
NMR Biomed; 2013 Nov; 26(11):1372-9. PubMed ID: 23703801
[TBL] [Abstract][Full Text] [Related]
13. Added value of susceptibility-weighted imaging to diffusion-weighted imaging in the characterization of parotid gland tumors.
Jiang JS; Zhu LN; Chen W; Chen L; Su GY; Xu XQ; Wu FY
Eur Arch Otorhinolaryngol; 2020 Oct; 277(10):2839-2846. PubMed ID: 32328768
[TBL] [Abstract][Full Text] [Related]
14. Tumor blood flow and apparent diffusion coefficient histogram analysis for differentiating malignant salivary tumors from pleomorphic adenomas and Warthin's tumors.
Tanaka F; Umino M; Maeda M; Nakayama R; Inoue K; Kogue R; Obara M; Sakuma H
Sci Rep; 2022 Apr; 12(1):5947. PubMed ID: 35396374
[TBL] [Abstract][Full Text] [Related]
15. Warthin tumor of the parotid gland: diagnostic value of MR imaging with histopathologic correlation.
Ikeda M; Motoori K; Hanazawa T; Nagai Y; Yamamoto S; Ueda T; Funatsu H; Ito H
AJNR Am J Neuroradiol; 2004 Aug; 25(7):1256-62. PubMed ID: 15313720
[TBL] [Abstract][Full Text] [Related]
16. Salivary glands: echo-planar versus PROPELLER Diffusion-weighted MR imaging for assessment of ADCs.
Juan CJ; Chang HC; Hsueh CJ; Liu HS; Huang YC; Chung HW; Chen CY; Kao HW; Huang GS
Radiology; 2009 Oct; 253(1):144-52. PubMed ID: 19789257
[TBL] [Abstract][Full Text] [Related]
17. Apparent diffusion coefficient (ADC) histogram analysis: differentiation of benign from malignant parotid gland tumors using readout-segmented diffusion-weighted imaging.
Zhang Z; Song C; Zhang Y; Wen B; Zhu J; Cheng J
Dentomaxillofac Radiol; 2019 Oct; 48(7):20190100. PubMed ID: 31265331
[TBL] [Abstract][Full Text] [Related]
18. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid.
Hu Z; Guo J; Feng J; Huang Y; Xu H; Zhou Q
Eur Radiol; 2023 Jun; 33(6):4453-4463. PubMed ID: 36502461
[TBL] [Abstract][Full Text] [Related]
19. Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results.
Karaman CZ; Tanyeri A; Özgür R; Öztürk VS
Dentomaxillofac Radiol; 2021 May; 50(4):20200391. PubMed ID: 33237812
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of salivary gland tumors through tumor heterogeneity: a comparison between pleomorphic adenoma and Warthin tumor using CT texture analysis.
Jung YJ; Han M; Ha EJ; Choi JW
Neuroradiology; 2020 Nov; 62(11):1451-1458. PubMed ID: 32621023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
